Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.    (DrugBank: Teicoplanin)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
299嚢胞性線維症1

299. 嚢胞性線維症 [臨床試験数:1,592,薬物数:1,539(DrugBank:255),標的遺伝子数:81,標的パスウェイ数:162
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,592 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04176328
(ClinicalTrials.gov)
October 25, 20198/11/2019Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis PatientsAn Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis PatientsCystic FibrosisDrug: Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.Neupharma SrlSintesi Research Srl;Aptuit Srl;Pari Pharma GmbHCompleted18 YearsN/AAll12Phase 1Italy